Skip Navigation


NDT Advance Access originally published online on February 2, 2006
Nephrology Dialysis Transplantation 2006 21(4):889-897; doi:10.1093/ndt/gfi254
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/4/889    most recent
gfi254v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cohen-Lahav, M.
Right arrow Articles by Douvdevani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen-Lahav, M.
Right arrow Articles by Douvdevani, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Experimental Nephrology

Vitamin D decreases NF{kappa}B activity by increasing I{kappa}B{alpha} levels

Merav Cohen-Lahav1,2, Shraga Shany1, David Tobvin2, Cidio Chaimovitz2 and Amos Douvdevani1,2

1 Department of Clinical Biochemistry and 2 Department of Nephrology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University, PO Box 151, Beer-Sheva, 84101, Israel

Correspondence and offprint requests to: Amos Douvdevani, PhD, Nephrology Laboratory, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel. Email: amosd{at}bgu.ac.il

Background. In a previous study we demonstrated the inhibitory effect of 1,25-dihydroxyvitamin D (1,25(OH)2D3) and its less calcaemic analog 1,24(OH)2D2 on the production of tumour necrosis factor alpha (TNF{alpha}) by human peritoneal macrophages. The aim of the present study is to examine whether this vitamin D inhibition of TNF{alpha} is mediated by its major transcription factor, nuclear factor-{kappa}B (NF{kappa}B).

Methods. Murine macrophage cells (P388D1) were incubated with 10–7 M 1,25(OH)2D3 or 1,24(OH)2D2 and then stimulated with lipopolysaccharide. NF{kappa}B activity was assayed using a reporter gene and by electrophoretic mobility shift assay (EMSA). In addition, we evaluated mRNA and protein levels of NF{kappa}B-p65 and of I{kappa}B{alpha}, a potent NF{kappa}B inhibitor, and phosphorylated I{kappa}B{alpha}.

Results. Both 1,25(OH)2D3 and 1,24(OH)2D2 induced a 60% reduction of TNF{alpha} secretion. By using a reporter gene and EMSA we found that vitamin D markedly reduced NF{kappa}B activity. 1,25(OH)2D3 or 1,24(OH)2D2 decreased NF{kappa}B-p65 levels in the nucleus and increased NF{kappa}B-p65 levels in the cytosol; no changes were observed in the total levels of NF{kappa}B-p65 protein and mRNA. Concurrently, vitamin D induced a significant increase in mRNA and protein levels of I{kappa}B{alpha} (~6.5- and 4.5-fold, respectively). Elevated levels of I{kappa}B{alpha} can be explained by the vitamin D-induced prolongation of I{kappa}B{alpha}-mRNA half-life from 110 to 190 min and by the decrease in I{kappa}B{alpha} phosphorylation.

Conclusions. Vitamin D up-regulates I{kappa}B{alpha} levels by increasing mRNA stability and decreasing I{kappa}B{alpha} phosphorylation. The increase in I{kappa}B{alpha} levels reduces nuclear translocation of NF{kappa}B and thereby downgrades its activity. Since NF{kappa}B is a major transcription factor of inflammatory mediators, these findings suggest that the less-calcaemic analog, 1,24(OH)2D2 may be effective as an anti-inflammatory therapeutic agent.

Keywords: I{kappa}B{alpha}; macrophages; NF{kappa}B; tumour necrosis factor alpha; vitamin D


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid
Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1059 - F1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
J. Immunol., August 1, 2007; 179(3): 1634 - 1647.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.